ADMISSION PROFILE OF ADULT AND ELDERLY PATIENTS WITH MALIGNANT PROSTATE NEOPLASM IN THE PUBLIC HEALTH NETWORK IN FLORIANÓPOLIS CITY
Malignant prostate neoplasia is one of the most common tumors in the world population, considered a cancer of old age. There are several factors that lead to the development of prostate cancer, including: a diet rich in red meat, fat, milk and dairy products; urinary tract senescence; smoking; alcoholism; family history and hormonal factors. The prostate is an exocrine gland of the androgen-dependent male urogenital system and its main function is to produce prostatic fluid. It is the size of a walnut, is located at the base of the bladder, has a fibroelastic texture and is divided into 3 parts. Patients with prostate cancer in more advanced stages may report urinary and ejaculatory symptoms. The diagnosis results from an investigation carried out by carrying out a range of tests, such as PSA, which is a protein physiologically released by the prostate, total PSA has a limit of 4 ng/mL, and values above the limit are suggestive of a deeper investigation. Furthermore, rectal examination is extremely important in screening for prostate neoplasms, it is based on palpation of the lower posterior prostatic region through the anal canal, and finally prostate biopsy is indicated when PSA levels are very high, it is performed a removal of tissue material and classified within the Gleason Score which is the sum of the primary (predominant) and secondary pattern. The Gleason Score can be represented as a well-differentiated tumor, with gleason 2-4, intermediate with gleason 5-6, poorly differentiated, gleason 7 and finally gleason 8-10 being an undifferentiated tumor, the last one with the worst prognosis. Interventional treatment of prostate cancer involves combining several measures that aim to eradicate malignant cells, such as surgery, radiotherapy, hormone therapy and chemotherapy.
ADMISSION PROFILE OF ADULT AND ELDERLY PATIENTS WITH MALIGNANT PROSTATE NEOPLASM IN THE PUBLIC HEALTH NETWORK IN FLORIANÓPOLIS CITY
-
DOI: 10.22533/at.ed.1593822305108
-
Palavras-chave: Prostatic, Neoplasm, Hospitalization, Incidence
-
Keywords: Prostatic, Neoplasm, Hospitalization, Incidence
-
Abstract:
Malignant prostate neoplasia is one of the most common tumors in the world population, considered a cancer of old age. There are several factors that lead to the development of prostate cancer, including: a diet rich in red meat, fat, milk and dairy products; urinary tract senescence; smoking; alcoholism; family history and hormonal factors. The prostate is an exocrine gland of the androgen-dependent male urogenital system and its main function is to produce prostatic fluid. It is the size of a walnut, is located at the base of the bladder, has a fibroelastic texture and is divided into 3 parts. Patients with prostate cancer in more advanced stages may report urinary and ejaculatory symptoms. The diagnosis results from an investigation carried out by carrying out a range of tests, such as PSA, which is a protein physiologically released by the prostate, total PSA has a limit of 4 ng/mL, and values above the limit are suggestive of a deeper investigation. Furthermore, rectal examination is extremely important in screening for prostate neoplasms, it is based on palpation of the lower posterior prostatic region through the anal canal, and finally prostate biopsy is indicated when PSA levels are very high, it is performed a removal of tissue material and classified within the Gleason Score which is the sum of the primary (predominant) and secondary pattern. The Gleason Score can be represented as a well-differentiated tumor, with gleason 2-4, intermediate with gleason 5-6, poorly differentiated, gleason 7 and finally gleason 8-10 being an undifferentiated tumor, the last one with the worst prognosis. Interventional treatment of prostate cancer involves combining several measures that aim to eradicate malignant cells, such as surgery, radiotherapy, hormone therapy and chemotherapy.
- Augusto Kenzo Colombo Ikeda
